Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Protalix Biotherapeutics Inc banner
P

Protalix Biotherapeutics Inc
F:PBDA

Watchlist Manager
Protalix Biotherapeutics Inc
F:PBDA
Watchlist
Price: 2.235 EUR -3.25%
Market Cap: €163.9m
Write Note Create Alert Ask AI

Wall St Price Targets

PBDA Price Targets Summary
Protalix Biotherapeutics Inc

Wall Street analysts forecast PBDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBDA is 8.33 EUR with a low forecast of 7.498 EUR and a high forecast of 9.355 EUR.

PBDA Lowest Forecast
Wall Street Target
€7.498
236% Upside
PBDA Average Forecast
Wall Street Target
€8.33
273% Upside
PBDA Highest Forecast
Wall Street Target
€9.355
319% Upside
Lowest Forecast
Price Target
7.498 EUR
236% Upside
Average Forecast
Price Target
8.33 EUR
273% Upside
Highest Forecast
Price Target
9.355 EUR
319% Upside
Protalix Biotherapeutics Inc Competitors:
Price Targets

Revenue
Forecast

3% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
3% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 10%.

What are analyst estimates?

Gross Profit
Forecast

0% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
0% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 6 years is 7%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

What are analyst estimates?

Continue PBDA Research

Summary
PBDA intrinsic value, competitors valuation, and company profile.
DCF Valuation
PBDA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PBDA stock valuation using valuation multiples.
Wall St Estimates
PBDA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PBDA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Protalix Biotherapeutics Inc listings:
AMEX • USD
PLX
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PBDA's stock price target?
Price Target
8.33 EUR

According to Wall Street analysts, the average 1-year price target for PBDA is 8.33 EUR with a low forecast of 7.498 EUR and a high forecast of 9.355 EUR.

What is the Revenue forecast for Protalix Biotherapeutics Inc?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 10%.

What is the Gross Profit forecast for Protalix Biotherapeutics Inc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 6 years is 7%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.